-
1561
Prediction of Other-Cause Mortality in Older Patients with Breast Cancer Using Comorbidity
Published 2021-04-01“…<i>Methods</i>: Surgically treated patients with stages I-III breast cancer aged ≥70 years diagnosed between 2003 and 2009 were selected from the Netherlands Cancer Registry. Competing risk analysis was performed to associate 5-year other-cause mortality with the Charlson index, comorbidity count, and specific comorbidities. …”
Get full text
Article -
1562
-
1563
Epidemiology of cervical cancer in Iran in 2016: A nationwide study of incidence and regional variation
Published 2024-02-01“…The study sample comprised all individuals registered as cervical cancer patients in the National Cancer Registry system in 2016. The crude rate and ASR for each province were computed independently. …”
Get full text
Article -
1564
-
1565
The Impact of Neighborhood Deprivation on the Survival Rates of Patients with Cancer in Korea
Published 2023-12-01Get full text
Article -
1566
Secular Trends in Incidence of Esophageal Cancer in Taiwan from 1985 to 2019: An Age-Period-Cohort Analysis
Published 2022-11-01“…We described the incidence trends of EC from 1985–2019 by an average annual percentage change (AAPC) and age-period-cohort model by using Taiwan Cancer Registry data. Age-period-cohort modeling was used to estimate the period and cohort effects of ESCC and esophageal adenocarcinoma (EAC). …”
Get full text
Article -
1567
Epidemiology and Histopathology of Nasopharyngeal Neoplasms in Iran
Published 2023-01-01“…Introduction: This study aimed to study the trend, histologic pattern, geographical distribution, and characteristics of nasopharyngeal carcinoma (NPC) and nasopharyngeal neoplasms (NPN) from 2003 to 2017 in Iran.Material and Methods: The Ministry of Health and Medical Education collected NPN cases from each province's corresponding university and stored them at Iran's National Cancer Registry (INCR) database. The Joinpoint program calculated the average annual percent change (AAPC) and its 95% confidence interval (CI). …”
Get full text
Article -
1568
Pharmacists’ approach to oncology medicine shortages: results of a cross-sectional survey in Pakistan
Published 2023-09-01“…The government should establish a cancer registry and drug shortage platform, revise drug prescribing/pricing policies and practice penalties for breaching regulations. …”
Get full text
Article -
1569
Immune Checkpoint Inhibitors-induced Thyroid Dysfunction in Patients with Advanced Malignancies
Published 2022-10-01“…The patients were identified through the hospital cancer registry. We retrospectively collected data regarding the subjects’ demographics, cancer type, type of ICIs, thyroid-related adverse events, and duration of treatment.Results: In the present paper, 43 patients received ICI and 19 (44%) developed thyroid dysfunctions. …”
Get full text
Article -
1570
Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy
Published 2018-03-01“…Materials and methods: Data on all men undergoing RP in Victoria between January 1, 2004 and December 31, 2014 were obtained from the Victorian Cancer Registry. Tumor characteristics including Gleason grade, stage of disease (based on final pathology specimen), and cause of death were also obtained. …”
Get full text
Article -
1571
The relative risk of second primary cancers in Austria’s western states: a retrospective cohort study
Published 2017-10-01“…Methods This retrospective cohort study included all invasive incident cancer cases diagnosed within the years 1988 to 2005 being registered in the Tyrol and Vorarlberg Cancer Registries. Person years at risk (PYAR) were calculated from time of first diagnosis plus 2 months until the exit date, defined as the date of diagnosis of the SPC, date of death, or end of 2010, whichever came first. …”
Get full text
Article -
1572
Cohort profile – the Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study in the Netherlands
Published 2023-03-01“…Information about disease characteristics, treatment of the primary tumour and clinical outcomes is being collected from medical records by the Netherlands Cancer Registry.Findings to date A total of 836 invited patients were eligible and 368 patients were willing to participate and were included (response rate 44%). …”
Get full text
Article -
1573
Molecular Classification of Endometrial Carcinoma: Protocol for a Cohort Study
Published 2022-08-01“…ResultsThis protocol was reviewed and approved by the Instituto Português de Oncologia do Porto, Portugal, ethics committee in October 2021; patient selection from our cancer registry began the same month. A total of 160 patients will be included. …”
Get full text
Article -
1574
Exploring Cancer Incidence, Risk Factors, and Mortality in the Lleida Region: Interactive, Open-source R Shiny Application for Cancer Data Analysis
Published 2023-04-01“…ResultsThe results provide a successful case study in which the tool was applied to the cancer registry of the Lleida region. The study illustrates how researchers and cancer registries can use the application to analyze cancer databases. …”
Get full text
Article -
1575
Cancer Incidence and Mortality Among Ethnic German Migrants From the Former Soviet Union
Published 2018-09-01Get full text
Article -
1576
Cost-effectiveness analysis of a community-based colorectal cancer screening program in Shanghai, China
Published 2022-10-01“…Colonoscopy was then recommended for positive results.ObjectiveTo evaluate the cost-effectiveness of the Community-Based Colorectal Cancer Screening Program in Shanghai, China from the payer perspective.MethodsThis analysis estimated the long-term cost and effectiveness of the 2014–2016 SHcsp based on real-world follow-up data from the SHcsp database, Shanghai Cancer Registry System, vital statistics from Shanghai Municipal Center for Disease Control and Prevention and inpatient CRC expense data from hospitals. …”
Get full text
Article -
1577
Investigation of racial differences in survival from non-small cell lung cancer with immunotherapy use: A Texas study
Published 2023-01-01“…However, there is limited information on whether the survival benefits associated with immunotherapy differ among races and ethnicities.ObjectiveThis study aimed to investigate racial differences in survival amongst patients with NSCLC who received immunotherapy as the first-line treatment in Texas.MethodsPatients with NSCLC who received immunotherapy between October 2015 to December 2018 were identified from the Texas Cancer Registry (TCR). Disease-specific survival was evaluated and compared among patients across racial/ethnic categories using the Kaplan-Meier survival analysis, log-rank test, and a multivariable Cox proportional hazard regression model following an inverse probability treatment weighting (IPTW) propensity score analysis.ResultsA total of 1453 patients were included in the analysis. …”
Get full text
Article -
1578
Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation
Published 2022-07-01“…A retrospective cohort study design was used including patients diagnosed with stage 0-III breast cancer in the Ontario Cancer Registry between 1 January 2009 and 31 December 2012 and alive six months post-diagnosis. …”
Get full text
Article -
1579
Deep learning for the detection of benign and malignant pulmonary nodules in non-screening chest CT scans
Published 2023-10-01“…A panel of five thoracic radiologists labeled all nodules, and two additional radiologists verified the nodule malignancy status and searched for any missed cancers using data from the national Netherlands Cancer Registry. The detection performance was evaluated by measuring the sensitivity at predefined false positive rates on a free receiver operating characteristic curve and was compared with the panel of radiologists. …”
Get full text
Article -
1580
Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline
Published 2023-06-01“…Methods: In this retrospective, population-based cohort study, cases of newly-diagnosed breast cancer were identified from the WA Cancer Registry. Linkage to the Hospital Morbidity Data Collection identified index BCS for invasive cancer between January 2009 and June 2018 (N = 8059) and reoperation within 90 days. …”
Get full text
Article